Latest Health News

Lightning Minerals Ltd’s securities remain suspended after missing a deadline to announce a major acquisition and capital raising, raising questions about the company’s next moves.

Adherium Limited has successfully closed the institutional portion of its entitlement offer, increasing the raise to $4.492 million due to robust demand. The company now invites retail shareholders to participate as it advances its digital respiratory health solutions.

Bowen Coking Coal Limited’s shares have been suspended from trading after missing a critical deadline to update the market on its funding efforts, casting uncertainty over its operational future.

Paradigm Biopharmaceuticals has acquired Proteobioactives, securing global rights to an oral combination therapy targeting early-stage osteoarthritis in humans and animals, complementing its injectable PPS phase 3 program.

Singular Health Group has completed a $7.85 million capital raising through a new share issue, alongside additional funds from option exercises, strengthening its financial position for growth in medical imaging technology.

The Star Entertainment Group is asking shareholders to approve a $400 million strategic investment package critical to its survival, involving convertible notes from Bally's and its largest shareholder. This move aims to secure the company’s future amid ongoing legal challenges and financial strain.

SRG Global has locked in $850 million worth of contracts spanning water, energy, resources, and more, reinforcing its position as a diversified infrastructure leader in Australia and New Zealand.

Indiana Resources Limited has announced a proposed capital return of five cents per share, backed by a draft ATO ruling confirming its tax-efficient status. The company plans a $32.2 million cash distribution, maintaining a strong balance sheet post-payment.

Treasury Wine Estates has secured Supreme Court approval for a $65 million settlement of a consolidated shareholder class action, allowing the company to focus on its strategic goals without admitting liability.

Cardiex Limited has successfully raised $4.1 million through a fully underwritten entitlement offer, bringing total funds raised to $6.5 million including a recent institutional placement. The offer saw strong participation from directors and key shareholders, with new shares set to be issued imminently.

Biotron Limited has completed the initial safety phase of its lead Hepatitis B drug in animal studies, paving the way for efficacy testing in two distinct mouse models. This milestone marks a significant step forward in the company’s antiviral drug development program.

Adherium Limited is raising up to $4 million through a partially underwritten entitlement offer to expand its US digital health platform and recruit key personnel. The capital raise supports scaling patient onboarding and advancing its FDA-cleared smart inhaler technology.